Search

everythinglearnresearchcommunity

for

Search:↓

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Progesterone may help trans women with breast development and health, but more research is needed.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Prenatal pesticide exposure may cause earlier breast development in girls.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

5alpha-reductase 2 is crucial for proper male brain development and sexual differentiation.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

African-American girls tend to start puberty earlier than white girls, possibly due to increased androgen production.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Mouse genital development depends on male or female hormones for specific features.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Testosterone makes XX skin more like male skin by changing its structure and cell makeup.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Testosterone treatment may affect heart response to stress in transgender men.